Study identifies enzyme mechanism driving tumor growth through altered ribosomes
Source Summary
Northwestern Medicine researchers have discovered a previously unknown mechanism by which an enzyme promotes cancer cell proliferation, involving altered ribosomes. The findings, published in Nature Communications, establish the enzyme as a promising therapeutic target for cancer treatment.
Why it matters
Identifying this enzyme mechanism as a therapeutic target could enable development of new cancer treatments that disrupt tumor growth at a molecular level.
